DEFM14A: Patterson Companies to be Acquired by Patient Square Capital for $31.35 Per Share in Cash Merger

Patterson Companies, Inc. announces a definitive agreement to be acquired by Paradigm Parent, LLC, an affiliate of Patient Square Capital, for $31.35 per share in cash.

Summary

• Patterson Companies, Inc. has entered into a merger agreement with Paradigm Parent, LLC, an affiliate of Patient Square Capital.
• Under the agreement, Paradigm Merger Sub, Inc. will merge with Patterson, with Patterson continuing as the surviving corporation and a wholly-owned subsidiary of Paradigm.
• Patterson shareholders will receive $31.35 in cash for each share of Patterson common stock they own.
• The merger consideration represents a premium of approximately 49% over the 30 calendar day volume-weighted average price ending December 4, 2024.
• The transaction is valued at approximately $4.1 billion.
• The Patterson board of directors has unanimously approved the merger agreement and recommends that shareholders vote in favor of the merger.
• The special meeting of shareholders to vote on the merger is scheduled for April 1, 2025.
• The merger is expected to close in April 2025, subject to shareholder approval and regulatory clearances.
• Upon completion of the merger, Patterson common stock will be delisted from NASDAQ and deregistered under the Exchange Act.

Sentiment

Score: 8

Explanation: The document is positive due to the high premium offered to shareholders and the board's unanimous recommendation to approve the merger. However, there are some risks associated with the transaction, such as the possibility of regulatory delays or the failure to obtain financing.

Positives

• Shareholders will receive a significant premium for their shares.
• The transaction provides certainty of value through an all-cash offer.
• The board of directors has unanimously approved the merger.
• The merger is expected to close relatively quickly.

Negatives

• Shareholders will no longer participate in the company's future growth.
• Patterson will cease to be a publicly traded company.

Risks

• The merger may not be completed if shareholder approval is not obtained.
• Regulatory clearances may not be received or may require divestitures.
• The financing may not be obtained.
• The company has received demand letters from shareholders alleging failures to disclose material information in the preliminary proxy statement.

Future Outlook

The company expects to complete the merger in April 2025, subject to shareholder approval and regulatory clearances. Upon completion of the merger, Patterson common stock will be delisted from NASDAQ and deregistered under the Exchange Act.

Management Comments

• The board of directors has unanimously approved the merger agreement and recommends that shareholders vote in favor of the merger.

Industry Context

The acquisition reflects continued consolidation activity in the healthcare distribution market, with private equity firms seeking opportunities to acquire established players.

Comparison to Industry Standards

• The merger consideration represents a premium of approximately 49% over the 30 calendar day volume-weighted average price ending December 4, 2024, which is a significant premium compared to recent transactions in the distribution industry.
• Comparable companies in the distribution sector, such as Henry Schein and Owens & Minor, trade at lower multiples than the implied valuation in this transaction.

Legal Proceedings

• The Company has received several demand letters from purported shareholders of the Company alleging failures to disclose material information in the preliminary proxy statement filed by the Company with the SEC in connection with the proposed Merger, which allegedly rendered the proxy statement false and misleading.

Stakeholder Impact

• Shareholders will receive a cash payment for their shares.
• Employees' future compensation and benefits are addressed in the merger agreement.
• The impact on customers and suppliers is not explicitly detailed but the company is expected to continue operating in the ordinary course until the merger is completed.

Next Steps

• The company will hold a special meeting of shareholders on April 1, 2025, to vote on the merger agreement.
• The company will work to obtain regulatory clearances.
• The parties will work to close the merger in April 2025.

Key Dates

Keywords

merger, acquisition, Patterson Companies, Patient Square Capital, Paradigm Parent, shareholders, agreement, cash, stock, board of directors